SANA · Categories · Form 4

SANA - SEC Form 4 insider transactions

Sana Biotechnology Inc. (SANA) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SANA

• 4d
  SEC Form 4 filed by Director Yang Patrick Y

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 4d
  SEC Form 4 filed by Director Rosiello Robert L.

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 4d
  SEC Form 4 filed by Director Seitz Michelle

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 4d
  SEC Form 4 filed by Director Reicin Alise

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 4d
  SEC Form 4 filed by Director Mulligan Richard

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 4d
  SEC Form 4 filed by Director Bishop Hans Edgar

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 4d
  SEC Form 4 filed by Director Bilenker Joshua H.

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 4d
  SEC Form 4 filed by Director Nelsen Robert

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 62d
  SEC Form 4 filed by Bishop Hans Edgar

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 91d
  President & CEO Harr Steve covered exercise/tax liability with 24,345 shares and converted options into 91,666 shares, increasing direct ownership by 0.85% to 7,944,251 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 91d
  Officer Wyrick Susan D. converted options into 13,666 shares and covered exercise/tax liability with 4,387 shares, increasing direct ownership by 5% to 196,196 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 95d
  SEC Form 4 filed by Officer Wyrick Susan D.

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 95d
  SEC Form 4 filed by President & CEO Harr Steve

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 97d
  Officer Wyrick Susan D. converted options into 1,525 shares and covered exercise/tax liability with 491 shares, increasing direct ownership by 0.56% to 186,917 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 111d
  SEC Form 4 filed by EVP, Chief Financial Officer Piper Brian

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 154d
  Director Bishop Hans Edgar was granted 6,157 shares, increasing direct ownership by 0.11% to 5,840,740 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 154d
  Officer Wyrick Susan D. converted options into 7,500 shares and covered exercise/tax liability with 2,407 shares, increasing direct ownership by 3% to 185,883 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 175d
  Officer Wyrick Susan D. converted options into 3,400 shares and covered exercise/tax liability with 873 shares, increasing direct ownership by 1% to 180,790 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 186d
  Officer Wyrick Susan D. converted options into 20,000 shares and covered exercise/tax liability with 5,132 shares, increasing direct ownership by 11% to 178,263 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 245d
  Director Bishop Hans Edgar was granted 5,628 shares, increasing direct ownership by 0.10% to 5,834,583 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 336d
  Director Bishop Hans Edgar was granted 7,842 shares, increasing direct ownership by 0.13% to 5,828,955 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 365d
  SEC Form 4 filed by Director Rosiello Robert L.

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 365d
  SEC Form 4 filed by Director Bilenker Joshua H.

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 365d
  SEC Form 4 filed by Director Bishop Hans Edgar

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 365d
  SEC Form 4 filed by Director Mulligan Richard

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 365d
  SEC Form 4 filed by Director Reicin Alise

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 365d
  SEC Form 4 filed by Director Nelsen Robert

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 365d
  SEC Form 4 filed by Director Seitz Michelle

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 365d
  SEC Form 4 filed by Director Wilderotter Mary Agnes

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 365d
  SEC Form 4 filed by Director Yang Patrick Y

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 427d
  Director Bishop Hans Edgar was granted 16,339 shares, increasing direct ownership by 0.28% to 5,821,113 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 456d
  Officer Wyrick Susan D. converted options into 3,250 shares and covered exercise/tax liability with 836 shares, increasing direct ownership by 2% to 157,395 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 456d
  EVP & General Counsel Cassidy Bernard J converted options into 11,041 shares and covered exercise/tax liability with 2,833 shares, increasing direct ownership by 8% to 112,990 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 456d
  President & CEO Harr Steve converted options into 50,000 shares and covered exercise/tax liability with 12,820 shares, increasing direct ownership by 0.47% to 7,876,930 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 463d
  Officer Wyrick Susan D. converted options into 1,525 shares and covered exercise/tax liability with 490 shares, increasing direct ownership by 0.67% to 154,981 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 515d
  See Remark 1 Fmr Llc sold $1,887,320 worth of shares (290,912 units at $6.49) (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 518d
  Director Bishop Hans Edgar was granted 14,285 shares, increasing direct ownership by 0.25% to 5,804,774 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 522d
  Officer Wyrick Susan D. converted options into 5,000 shares and covered exercise/tax liability with 1,566 shares, increasing direct ownership by 2% to 153,946 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 608d
  Director Bishop Hans Edgar was granted 5,938 shares, increasing direct ownership by 0.10% to 5,790,489 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 621d
  Director Mulligan Richard sold $1,195,740 worth of shares (300,000 units at $3.99), decreasing direct ownership by 10% to 2,698,121 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 694d
  Amendment: SEC Form 4 filed by Director Yang Patrick Y

  4/A - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 694d
  Amendment: SEC Form 4 filed by Director Mulligan Richard

  4/A - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 694d
  Amendment: SEC Form 4 filed by Director Nelsen Robert

  4/A - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 694d
  Amendment: SEC Form 4 filed by Director Wilderotter Mary Agnes

  4/A - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 694d
  Amendment: SEC Form 4 filed by Director Seitz Michelle

  4/A - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 694d
  Amendment: SEC Form 4 filed by Director Reicin Alise

  4/A - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 694d
  Amendment: SEC Form 4 filed by Director Cole Douglas G.

  4/A - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 694d
  Amendment: SEC Form 4 filed by Director Bishop Hans Edgar

  4/A - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 694d
  Amendment: SEC Form 4 filed by Director Bilenker Joshua H.

  4/A - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 701d
  Director Bishop Hans Edgar was granted 4,911 shares, increasing direct ownership by 0.08% to 5,784,551 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 732d
  SEC Form 4 filed by Mulligan Richard

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 732d
  SEC Form 4 filed by Nelsen Robert

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 732d
  SEC Form 4 filed by Wilderotter Mary Agnes

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 732d
  SEC Form 4 filed by Seitz Michelle

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 732d
  SEC Form 4 filed by Reicin Alise

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 732d
  SEC Form 4 filed by Cole Douglas G.

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 732d
  SEC Form 4 filed by Bilenker Joshua H.

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 732d
  SEC Form 4 filed by Bishop Hans Edgar

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 732d
  SEC Form 4 filed by Yang Patrick Y

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)
• 792d
  Bishop Hans Edgar was granted 2,774 shares, increasing direct ownership by 0.05% to 5,779,640 units (SEC Form 4)

  4 - Sana Biotechnology, Inc. (0001770121) (Issuer)

Other SANA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends